e-learning
resources
Paris 2018
Tuesday, 18.09.2018
ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary arterial hypertension: treatment options
O. Sitbon (Le Kremlin-Bicêtre, France)
Source:
International Congress 2018 – ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED
Session:
ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED
Session type:
Meet the expert
Number:
4844
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Sitbon (Le Kremlin-Bicêtre, France). Pulmonary arterial hypertension: treatment options. International Congress 2018 – ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Treatment options for paediatric pulmonary arterial hypertension
Source: Eur Respir Rev 2010 19: 321-330
Year: 2010
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed
Source: Eur Respir J 2010; 36: 986-990
Year: 2010
Adherence to pulmonary arterial hypertension targeted therapies
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation
Source: Eur Respir Rev 2014; 23: 488-497
Year: 2014
Identification of treatment goals in paediatric pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 1616-1626
Year: 2014
Pulmonary arterial hypertension: tailoring treatment to risk in the current era
Source: Eur Respir Rev, 26 (146) 170095; 10.1183/16000617.0095-2017
Year: 2017
Pulmonary arterial hypertension in patients treated with interferon
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Current medical treatment of pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
Current medical treatment of pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
Current medical treatment of pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
Current medical treatment of pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017
The future of treatment for pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
The future of treatment for pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
The future of treatment for pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017
The future of treatment for pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Pulmonary rehabilitation in patients with pulmonary arterial hypertension
Source: ERS Course 2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept